26/05/2023 - 17:45 Financial Convocation for the annual general meeting of Gimv on June 28th, 2023 Read more
24/05/2023 - 14:29 Portfolio ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002 Read more
17/05/2023 - 06:58 Financial Portfolio reaches a record level in a challenging economic environment Read more
25/04/2023 - 17:43 Portfolio Gimv Smart Industries invests in Witec, a fast-growing developer and manufacturer of high-precision and high-tech parts and systems for leading OEM customers Read more
25/04/2023 - 07:28 Portfolio Fronnt boosts its ambitious growth trajectory and energy transition mission with the entry of three new leading installation companies Read more
17/04/2023 - 07:27 Portfolio Gimv leads a 72 million € Series A financing round of Complement Therapeutics to finance further development of therapies for eye diseases Read more
15/03/2023 - 16:27 Portfolio FIRE1 Raises $25 Million to Revolutionize Heart Failure Home Monitoring Read more
15/03/2023 - 07:28 Portfolio Gimv participates in $105 million financing of Mediar Therapeutics alongside fellow leading global life sciences investors to develop first-in-class fibrosis therapies Read more
09/03/2023 - 07:30 Corporate news Gimv recognized as an ESG top performer and joins the BEL® ESG Index Read more
21/02/2023 - 07:30 Portfolio Gimv participates in Paleo’s Series A of EUR 12m, a Belgian pioneer in the alternative protein market Read more
14/02/2023 - 14:16 Portfolio Olyn acquires Mozoo and strengthens its expertise in brand content Read more
09/02/2023 - 07:30 Financial KÖBERL Group expands in the attractive pipeline cleaning and wastewater technology segment Read more
27/01/2023 - 07:00 Portfolio AgTech leader Kind Technologies attracts growth capital from Avedon to further develop its innovative offering. Avedon additionally acquires Gimv’s majority stake in the group. Read more
26/01/2023 - 07:00 Portfolio Biotalys Achieves Significant Progress in Manufacturing Capabilities for Evoca Read more
23/12/2022 - 07:45 Portfolio Gimv invests in the energy transition and critical infrastructure in Germany and announces a partnership with Rohrleitungsbau Münster Read more
09/12/2022 - 07:30 Portfolio Gimv exits Biolam to its management backed by investors after a fast and successful growth trajectory into a leading French group of clinical testing labs Read more
14/11/2022 - 11:08 Portfolio The joining of forces by Arseus Medical and Pro-Motion Medical represents a starting point for the expansion of a unique platform for orthopaedic devices in the Low Countries. Read more
07/11/2022 - 08:30 Portfolio Acquisition of Control Mechatronics expands E.GRUPPE’s product range and continues its growth trajectory Read more
28/10/2022 - 09:00 Portfolio ProjectiveGroup grows further with acquisition of Dutch Charco & Dique Read more
18/10/2022 - 07:30 Portfolio With the support of Gimv, Groupe Claire acquires E.I.E. from Sade, a subsidiary of Veolia Read more
21/09/2022 - 07:30 Portfolio Gimv partners with the founders of Les Psy Réunis group to develop a leading outpatient mental care provider in Switzerland Read more
27/07/2022 - 17:45 Financial Outcome of the optional dividend for the financial year 2021/2022: 53.3% of the dividend rights on the financial year 2021/2022 are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 25.9 million Read more
20/07/2022 - 08:20 AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma Read more
13/07/2022 - 07:30 Portfolio Gimv transfers stake in the Eurocept group - active in "Hospital-at-home" services, outpatient clinics and specialty pharmaceuticals - to its founder Read more
